LOS ANGELES and DESERT HOT SPRINGS, Calif. — via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, is pleased to announce that its licensed distribution partner Medz Cannabis has filed a Notice of New Cannabis Product (“NNCP”) with Health Canada on Grapefruit’s behalf. Approval of the NNCP by Health Canada will enable Grapefruit to sell its patented Hourglass™ Time Release THC+CBD-Infused Topical Delivery Cream to licensed retail outlets throughout Canada.
Health Canada is the Canadian federal government department that is responsible for national health policy. It approves and oversees the production of all cannabis products and is the licensing authority for all companies involved in the cannabis industry. Health Canada requires that all cannabis products meet federal regulatory requirements before they can be sold in Canada. Under Canada’s Federal Cannabis Regulatory scheme, Health Canada must be notified of a company’s intent to sell a cannabis product that has not previously been sold in the country. Approval of the NNCP is a mandatory prerequisite to the launch of Grapefruit’s Hourglass technology-based products in Canada. Accordingly, Grapefruit’s NNCP has been submitted to Health Canada in anticipation of its approval and Grapefruit’s subsequent sales launch of Hourglass technology-based THC and CBD products in Canada in 2022.
Grapefruit believes its Hourglass™ THC/CBD delivery cream system is a truly disruptive technology that has fundamentally changed the way humans safely ingest THC, CBD and other cannabinoids to enjoy their unique holistic benefits without the dangers of smoking and oral ingestion. A simple application of Grapefruit’s Hourglass™ THC/CBD/cannabinoid cream is all that is needed for Hourglass users to obtain the full-body entourage effects and related benefits of THC, CBD and a wide array of other beneficial cannabinoids. The disruptive Hourglass delivery system enables humans, for the first time, to effectively use a variety of cannabis products in a healthy fashion. Simply put, Hourglass works without the associated health risks from smoking or orally ingesting THC and CBD.
Bradley J. Yourist, Grapefruit’s CEO and co-founder, commented, “We are pleased to launch our Canadian Hourglass initiative. We are confident that Canadians who wish to enjoy the holistic benefits of THC/CBD and other cannabinoids without smoking or eating them will embrace Hourglass THC/CBD/cannabinoid cream.”
For additional information about Hourglass Canada, please visit: https://grapefruitblvd.com/hourglass-canadian-launch/
To purchase Grapefruit’s groundbreaking CBD delivery relief cream outside of Canada, please visit: https://hourglassonlinestore.com/
To learn more about Grapefruit’s new sustained-release Hourglass™ THC+Cannabinoid Topical Delivery Cream, please watch this promotional video: https://www.youtube.com/watch?v=6cU9MJMgH1w&feature=youtu.be
and visit our website at:
https://grapefruitblvd.com/hourglass/
Follow us on Facebook, Instagram, LinkedIn and Twitter:
Facebook | Instagram | LinkedIn | Twitter
About Grapefruit
Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. To obtain further information on Grapefruit and its operations, please visit the Company’s website at https://grapefruitblvd.com/.
Safe Harbor Statement
Grapefruit cautions that any statement included in this press release that is not a description of historical facts is a forward-looking statement. Many of these forward-looking statements contain the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties inherent in Grapefruit’s business, including, without limitation: the Company may not ever obtain additional funds necessary to support its business development and growth plans; and the Company may not ever achieve the market success to reach or sustain a profitable business. In addition, there are risks and uncertainties related to economic recession or terrorist actions, competition from much larger cannabis companies, unexpected costs and delays, potential product liability claims and many other factors. More detailed information about Grapefruit and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, its Quarterly Report on Form 10-Q for the period ended Sept. 30, 2021, and its Registration Statement on Form S-1/A. Such documents may be read free of charge on the SEC’s website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Grapefruit undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
- Nebraska medical cannabis backers file legal challenge to petition process
Supporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot. - N.J. lawmakers seek to curb cannabis use
As New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job. - Missouri House votes to require disclosure of medical cannabis ownership records
The Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view. - Nebraska medical cannabis group calls for ‘grassroots’ effort after losing donor
Unable to raise $1 million to replace funds from a major donor who died, Nebraskans for Medical Marijuana issued a plea Friday for supporters of the cause to take up petitions and gather signatures. - Lawmaker says GOP resistance may doom Missouri cannabis legalization
A Republican lawmaker pushing legislation to legalize recreational marijuana in Missouri says his bill is in jeopardy because of stall tactics by his GOP colleagues and the insistence of the House floor leader that it include license caps. - SD cannabis legalization campaign to submit signatures for November
Today, South Dakotans for Better Marijuana Laws, the political group that led the 2020 campaign to legalize cannabis in South Dakota, submitted petitions to place an adult-use cannabis legalization initiated measure on the November 2022 ballot. - NH senate votes down legal cannabis bills, ending chances for 2022
The New Hampshire Senate voted down two bills to legalize cannabis Thursday, likely heading off the last opportunities for legalization in the Granite State this year. - Last Prisoner Project: Taking Real Action to Help Cannabis Prisoners
“It really remains a fundamental injustice,” said Stephen Post, of America’s criminalization of cannabis. “We’re really helping to try to turn around those injustices.” Post works as a campaign manager for Last Prisoner Project (LPP), a nonprofit assisting cannabis prisoners. - Federal attempts to legalize cannabis flail, while public support grows
Across the country, attitudes toward cannabis are becoming more permissive and accepting, but partisan gridlock in Congress virtually ensures that legislation to decriminalize marijuana will languish and die in the U.S. Senate. - Wisconsin GOP medical cannabis bill gets 4/20 public hearing
The bill, authored by Sen. Mary Felzkowski (R-Irma), would legalize medicinal use of cannabis under specific conditions. Patients would need to be registered, and the cannabis must be in the form of a liquid, oil, pill, tincture or topical ointment.